The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Fresenius Medical Care AG & Co KGaA

NYSE: FMS
Last

(U.S.) $43.63

Today's change-0.45 -1.02%
Updated April 29 4:02 PM EDT. Delayed by at least 15 minutes.
 

Fresenius Medical Care AG & Co KGaA

NYSE: FMS
Last

(U.S.) $43.63

Today's change-0.45 -1.02%
Updated April 29 4:02 PM EDT. Delayed by at least 15 minutes.

Fresenius Medical Care AG & Co KGaA down (U.S.)$0.45

Fresenius Medical Care AG & Co KGaA closed lower Friday, dropping (U.S.)$0.45 or 1.02% to (U.S.)$43.63. Shares have lost 2.22% over the last five days, but sit 4.84% below their 52-week high. This security has outperformed the S&P 500 by 5.68% during the last year.

Key company metrics

  • Open(U.S.) $43.73
  • Previous close(U.S.) $44.08
  • High(U.S.) $43.78
  • Low(U.S.) $43.35
  • Bid / Ask-- / --
  • YTD % change+4.28%
  • Volume133,436
  • Average volume (10-day)130,149
  • Average volume (1-month)121,126
  • Average volume (3-month)215,819
  • 52-week range(U.S.) $36.89 to (U.S.) $45.85
  • Beta0.59
  • Trailing P/E25.84×
  • P/E 1 year forward21.11×
  • Forward PEG2.11×
  • Indicated annual dividend(U.S.) $0.44
  • Dividend yield1.01%
  • Trailing EPS(U.S.) $1.69
Updated April 29 4:02 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+7.85%

Based on its net profit margin of 7.85%, Fresenius Medical Care AG & Co KGaA is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.47%Sector:Industry:

Latest Company News

    No News Results.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue4,3484,2314,1993,960
Total other revenue--------
Total revenue4,3484,2314,1993,960
Gross profit1,4681,3821,2971,184
Total cost of revenue2,8792,8502,9012,776
Total operating expense3,6863,6183,6523,456
Selling / general / administrative788770714655
Research & development40353431
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income662614547504
Interest income (expense), net non-operating-125-106-115-162
Gain (loss) on sale of assets--------
Other--------
Income before tax574514445402
Income after tax393346310264
Income tax, total180168135138
Net income317262241210
Total adjustments to net income--------
Net income before extra. items317262241210
Minority interest-77-83-69-55
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items317262241210
Inc. avail. to common incl. extra. items317262241210
Diluted net income317262241210
Dilution adjustment----0--
Diluted weighted average shares304305305305
Diluted EPS excluding extraordinary itemsvalue per share1.040.860.790.69
Dividends per sharevalue per share0.000.000.870.00
Diluted normalized EPSvalue per share1.040.860.790.69